EnzySurge Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Employees
  • 106
Employees
  • Latest Deal Type
  • 2ndary - Private

EnzySurge General Information

Description

Developer of wound management products designed to ensure effective anti-bacterial preservative activity. The company's product cleans, moisturizes and soothes chronic and hard-to-treat wounds and prevents maceration, enabling doctors to easily treat stasis ulcers, diabetic foot ulcers, post-surgical wounds, first and second degree burns, cuts, abrasions and minor skin irritations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Other Devices and Supplies
Primary Office
  • 26 Shabazi Street
  • Rosh Ha'Ayin 48021
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EnzySurge Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-May-2021 000.00 Completed Generating Revenue
4. Angel (individual) 05-Jan-2010 00.00 000.00 0000 Completed Generating Revenue
3. Later Stage VC 03-Jun-2008 000 00.00 Completed Startup
2. Early Stage VC 31-Dec-2006 $1.7M $3.7M 000 Completed Startup
1. Angel (individual) $2M $2M Completed Startup
To view EnzySurge’s complete valuation and funding history, request access »

EnzySurge Patents

EnzySurge Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-8241260-B2 Liquid streaming devices for treating wounds, method of making such devices, and method of using such devices for treating wounds Expired - Fee Related 21-Apr-2008 000000000 00
US-9044532-B2 Liquid streaming devices and method of using such devices for treating wounds Active 21-Apr-2008 0000000000 00
US-20130304001-A1 Liquid streaming devices and method of using such devices for treating wounds Granted 21-Apr-2008 00000000
US-20090264838-A1 Liquid streaming devices for treating wounds, method of making such devices, and method of using such devices for treating wounds Granted 21-Apr-2008 00000000 00
JP-2011519295-A Liquid streaming device for treating a wound and method of using the device to treat a wound Pending 21-Apr-2008 A61M27/00
To view EnzySurge’s complete patent history, request access »

EnzySurge Executive Team (5)

Name Title Board Seat Contact Info
Yaron Menashe Chief Executive & Finance Officer & Board Member
Moshe Landsberg Chief Executive Officer
Itschak Nomkin Director of Finance
Amihay Freeman Founder & Chief Scientist
You’re viewing 4 of 5 executive team members. Get the full list »

EnzySurge Board Members (7)

Name Representing Role Since
Avi Gros EnzySurge Board Member 000 0000
Dan Koren EnzySurge Chairman 000 0000
Eliezer Gilboa Self Board Member 000 0000
Nathan Avisar EnzySurge Board Member 000 0000
Shmulik Cohen Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

EnzySurge Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial